BUY MBP RUXOLITINIB JAKAVI 15MGTAB 14’S BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Ruxolitinib is a prescription medicine used to treat certain blood and bone marrow disorders, particularly myelofibrosis, polycythaemia vera, and graft-versus-host disease (GVHD). It works by blocking specific enzymes in the body known as Janus kinases (JAK1 and JAK2), which are involved in inflammation and abnormal blood cell production. By reducing the activity of these enzymes, ruxolitinib helps control disease symptoms, reduce inflammation, and improve quality of life.

Ruxolitinib works by interrupting abnormal signalling pathways that cause excessive production of blood cells and inflammatory chemicals. In conditions like myelofibrosis, this helps reduce an enlarged spleen, improve fatigue, night sweats, itching, bone pain, and weight loss. In graft-versus-host disease, ruxolitinib helps calm an overactive immune response that attacks healthy tissues after a stem cell transplant.

Ruxolitinib is taken by mouth, usually twice daily, with or without food. The dose depends on the medical condition being treated, platelet count, kidney and liver function, and overall response to therapy. It is very important to take ruxolitinib exactly as prescribed and not to stop it suddenly unless advised by a healthcare professional, as sudden discontinuation may worsen symptoms or cause a rebound effect.

One of the most common effects of ruxolitinib is suppression of blood cell production. This can lead to low red blood cells (anaemia), low white blood cells (increasing infection risk), and low platelets (increasing bleeding risk). Regular blood tests are required to monitor blood counts, especially during the first few months of treatment.

Common side effects include tiredness, dizziness, headache, bruising, weight gain, increased cholesterol levels, and mild infections such as colds or urinary tract infections. Some people may also experience gastrointestinal symptoms such as diarrhoea or constipation.

Because ruxolitinib affects the immune system, it can increase the risk of infections, including serious ones such as tuberculosis, shingles, or fungal infections. Patients should report symptoms such as fever, persistent cough, unexplained weight loss, or night sweats promptly. Vaccinations should be discussed with a healthcare provider before starting treatment, and live vaccines should generally be avoided.

Ruxolitinib may also slightly increase the risk of certain skin cancers, so regular skin checks and sun protection are recommended. Any new or changing skin lesions should be reported.

This medicine can interact with other drugs, particularly strong inhibitors or inducers of liver enzymes such as certain antifungals, antibiotics, and antiviral medicines. Always inform your healthcare provider about all medications, supplements, or herbal products being used.

Ruxolitinib should not be used during pregnancy unless clearly necessary, as it may harm the unborn baby. Effective contraception is recommended during treatment and for some time after stopping the medication. Breastfeeding is not recommended while taking ruxolitinib.

When taken as prescribed and closely monitored, ruxolitinib can significantly improve symptoms, reduce spleen size, and enhance quality of life for people with myeloproliferative disorders or graft-versus-host disease. Regular follow-up, blood tests, and open communication with the healthcare team are essential to ensure safe and effective treatment.